CIK 0001761918 · <br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition General Counsel & Corp. Sec. acquired 990 shares (other)
- 4 Other acquisition Chief Medical Officer acquired 1,562 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Chief Financial Officer acquired 1,562 shares (other)
- 4 Open-market buy Director bought 200,000 shares at $22.10 ($4,420,000)
- 4 Open-market buy Director bought 950,000 shares at $16.00 ($15,200,000)
- 4 Conversion See Remarks acquired 10,576,417 shares (conversion)
- 4 Open-market buy General Counsel bought 900 shares at $16.00 ($14,400)
- 4 Conversion Director acquired 900,000 shares (conversion)
- 4 Conversion 10% owner acquired 11,055,554 shares (conversion)
- 4 Open-market buy Director bought 2,000 shares at $16.00 ($32,000)
- 4 Open-market buy Director bought 6,200 shares at $16.00 ($99,200)
- 4 Open-market buy Director bought 6,000 shares at $16.00 ($96,000)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 6 of 7 · 127 filings